GHK-Cu (Copper Peptide) (Topical)

GHK-Cu is a copper-binding form of the endogenous tripeptide GHK (glycyl-histidyl-lysine) and is classified as a small regulatory peptide–metal complex studied in molecular and cellular biology research. It was originally identified in human plasma and has since been investigated for its interactions with copper-dependent enzymatic systems and gene-regulatory pathways.

In laboratory settings, GHK-Cu is examined for its association with transcriptional modulation across pathways involved in extracellular matrix dynamics, inflammatory mediator signaling, oxidative balance, and cellular stress adaptation. Because copper functions as a redox-active cofactor in numerous enzymatic reactions, complexation with GHK provides a model for studying controlled copper delivery and its downstream molecular effects. Research frequently compares GHK-Cu to peptide-alone and copper-alone controls to isolate metal-dependent signaling influences within defined experimental systems.

Peptide Sequence: Gly-His-Lys (Cu²⁺)
Molecular Class: Copper-complexed tripeptide
Metal Coordination: Cu²⁺ bound via histidine and amine residues

GHK exhibits strong affinity for copper ions, and copper coordination can support distinct biochemical behavior compared to the non-complexed tripeptide. In research settings, this copper-binding property is used to explore metal-dependent regulation of ECM synthesis and remodeling, as well as copper-sensitive oxidative stress and signaling pathways. ^[1]

GHK-Cu is studied in vitro and in animal models to evaluate measurable molecular and cellular changes relative to appropriate control groups. Common endpoints include extracellular matrix–associated gene expression (such as collagen, elastin, and decorin targets), fibroblast proliferation markers, cytokine signaling profiles (including IL-6, TNF, and NF-κB–associated pathways), and oxidative-stress biomarkers.

Transcriptomic studies have reported broad shifts in gene-expression patterns under controlled exposure conditions, including modulation of antioxidant-response genes, DNA-repair–associated markers, and ubiquitin–proteasome system components. In preclinical tissue models, researchers may assess histological remodeling markers, vascularization indicators, and inflammatory mediator expression compared to untreated or vehicle-treated controls.

All reported findings are interpreted within the parameters of the specific experimental design, including model type, concentration, duration, and assay methodology. These observations are confined to laboratory and preclinical research contexts and do not imply clinical application or therapeutic use.

Mechanistic research on GHK-Cu commonly explores pathway-level effects related to ECM remodeling and cell–matrix communication, including signaling environments associated with matrix synthesis and organization. Studies have also discussed gene-expression modulation across panels relevant to inflammatory signaling, angiogenic regulators, cell-cycle control, and structural matrix proteins in preclinical and in-vitro systems. ^[1]

In fibroblast-focused models, publications have reported ECM-associated readouts consistent with collagen and matrix component regulation in culture systems, supporting use of GHK-Cu as a laboratory probe in matrix biology research. ^{[2], [3]}

Preclinical investigations of GHK-Cu include studies in cultured fibroblasts and skin-relevant cellular systems, with reported outcomes focusing on ECM-related biosynthesis and remodeling markers. Additional research discussions have summarized broader gene-expression and signaling effects in experimental models. All findings are limited to laboratory and experimental research settings and are not indicative of clinical performance. ^[1]

Product identity and purity are commonly verified using established analytical techniques such as HPLC and mass spectrometry (MS), supporting batch-to-batch consistency for research reproducibility.

The following quality documentation is provided to support product identity, purity, and analytical verification for laboratory research use. All analyses are batch-specific and supplied for informational and reproducibility purposes only.

Certificate of Analysis (COA)

High Performance Liquid Chromatography (HPLC)

Mass Spectrometry (MS)

1. Pickart L et al. BioMed Research International. 2015.
2. Maquart FX et al. FEBS Letters. 1988;238(2):343–346.
3. Siméon A et al. Journal of Investigative Dermatology. 2000;115(6):962–968.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

For Laboratory Research Only. Not for human use, medical use, diagnostic use, or veterinary use.